MOXIFLOXACIN 0.5%w/v IP + BENZALKONIUM CHLORIDE 0.02%v/v IP

An anti-infective broad-spectrum bactericidal drug against common ocular pathogens. (Miller, 2008) Exerts potent and rapid bactericidal activity against the most common gram-positive postoperative endophthalmitis pathogens. (Terrence P O'Brien, 2007) A prophylactic antibiotic that lowers the risk of acute postoperative bacterial endophthalmitis. (Seenu M Hariprasad, 2004) A valuable agent that offers powerful advantages for ophthalmic therapy. (Stella M Robertson, 2005) Lessens the bacterial load on lid margins and conjunctiva of patients undergoing cataract surgery. (Frank A Bucci, 2015) Has high potency against a broad range of microbial species and a favorable profile in terms of safety and tolerability. (Eduardo Alfonso, 2005) Displays a significantly higher clinical cure rate than trimethoprim 1.0%/polymyxin B 10,000 IU/mL ophthalmic solution in patients with bacterial conjunctivitis. (Keating, 2011) A safe and well-tolerated medicine in pediatric and non-pediatric patients with bacterial conjunctivitis. (Lewis H Silver, 2005)